Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-12

Clinical Trial Update: Vinorelbine in Mesothelioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Vinorelbine in mesothelioma (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vinorelbine (Vinorelbine)

Snippet

Sponsor: Wales Cancer Trials Unit | Conditions: Mesothelioma | Phase 2 | Status: COMPLETED